Whether you're working with Retatrutide, Tesamorelin, BPC-157, MOTS-c, or another research peptide, the underlying laboratory principles remain largely the same
A clinical trial from Spain treated adults, with an average age of 74, for eight weeks with 1,000 g of cyanocobalamin per day and then for another 46 weeks with 1,000 g per week
It is not intended for human or animal consumption, clinical, diagnostic, therapeutic, dietary, or veterinary use
[17] These effects, if they occur, tend to resolve within a short time
Huberman notes that the peptide BPC-157 shows promise in tissue repair, but stresses that more clinical trials are needed to validate its use for longevity